HRP20040900B1 - Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor x<sub>a</sub> - Google Patents

Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor x<sub>a</sub>

Info

Publication number
HRP20040900B1
HRP20040900B1 HR20040900A HRP20040900A HRP20040900B1 HR P20040900 B1 HRP20040900 B1 HR P20040900B1 HR 20040900 A HR20040900 A HR 20040900A HR P20040900 A HRP20040900 A HR P20040900A HR P20040900 B1 HRP20040900 B1 HR P20040900B1
Authority
HR
Croatia
Prior art keywords
sub
inhibitors
cyclopropylglycinyl
piperidin
certain
Prior art date
Application number
HR20040900A
Other languages
English (en)
Inventor
Robert Wiley Michael
Lowell Engel Gary
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of HRP20040900A2 publication Critical patent/HRP20040900A2/xx
Publication of HRP20040900B1 publication Critical patent/HRP20040900B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Spoj formule (I) naznačen time što R predstavljaatom vodika ili atom fluora, ili njegova farmaceutski prihvatljiva sol. Patent sadrži još 14 patentnih zahtjeva.
HR20040900A 2002-04-01 2004-09-30 Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor x<sub>a</sub> HRP20040900B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36852302P 2002-04-01 2002-04-01
PCT/US2003/007794 WO2003084929A1 (en) 2002-04-01 2003-03-24 Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa

Publications (2)

Publication Number Publication Date
HRP20040900A2 HRP20040900A2 (en) 2004-12-31
HRP20040900B1 true HRP20040900B1 (en) 2006-02-28

Family

ID=28791889

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20040900A HRP20040900B1 (en) 2002-04-01 2004-09-30 Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor x<sub>a</sub>

Country Status (25)

Country Link
US (1) US7166606B2 (hr)
EP (1) EP1492767B1 (hr)
JP (1) JP2005531529A (hr)
KR (1) KR20040094892A (hr)
CN (1) CN1288135C (hr)
AT (1) ATE303990T1 (hr)
AU (1) AU2003218147A1 (hr)
BR (1) BR0308870A (hr)
CA (1) CA2478340A1 (hr)
CR (1) CR7497A (hr)
DE (1) DE60301569T2 (hr)
DK (1) DK1492767T3 (hr)
EA (1) EA007300B1 (hr)
EC (1) ECSP045329A (hr)
ES (1) ES2248737T3 (hr)
HK (1) HK1070363A1 (hr)
HR (1) HRP20040900B1 (hr)
IL (1) IL164018A0 (hr)
MX (1) MXPA04009640A (hr)
NO (1) NO20044688L (hr)
NZ (1) NZ535402A (hr)
PL (1) PL373066A1 (hr)
UA (1) UA76849C2 (hr)
WO (1) WO2003084929A1 (hr)
ZA (1) ZA200407418B (hr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6834308B1 (en) 2000-02-17 2004-12-21 Audible Magic Corporation Method and apparatus for identifying media content presented on a media playing device
EP1490767B1 (en) 2001-04-05 2014-06-11 Audible Magic Corporation Copyright detection and protection system and method
US8972481B2 (en) 2001-07-20 2015-03-03 Audible Magic, Inc. Playlist generation method and apparatus
DE102014108210A1 (de) 2014-06-11 2015-12-17 Dietrich Gulba Rodentizid
US11014920B2 (en) 2016-11-18 2021-05-25 Merck Sharp & Dohme Corp. Factor XIIa inhibitors
EP4070658A1 (de) 2021-04-06 2022-10-12 BIORoxx GmbH Verwendung von blutgerinnungshemmenden verbindungen als rodentizide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1012166B1 (en) 1997-08-29 2003-10-29 Tularik Limited 1-amino-7-isoquinoline derivatives as serine protease inhibitors
EP1192132B1 (en) 1999-06-14 2005-09-07 Eli Lilly And Company Serine protease inhibitors
EP1192135A2 (en) 1999-06-14 2002-04-03 Eli Lilly And Company Serine protease inhibitors
GB0030304D0 (en) * 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030305D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030306D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030303D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
TWI257389B (en) 2001-06-12 2006-07-01 Lilly Co Eli Pharmaceutical compound
US7265121B2 (en) * 2001-07-26 2007-09-04 Eli Lilly And Company Chemical compounds

Also Published As

Publication number Publication date
NO20044688L (no) 2004-10-29
HRP20040900A2 (en) 2004-12-31
WO2003084929A8 (en) 2004-05-21
CA2478340A1 (en) 2003-10-16
CR7497A (es) 2005-01-17
JP2005531529A (ja) 2005-10-20
DK1492767T3 (da) 2005-11-28
NZ535402A (en) 2006-02-24
DE60301569T2 (de) 2006-06-14
EP1492767B1 (en) 2005-09-07
ATE303990T1 (de) 2005-09-15
PL373066A1 (en) 2005-08-08
BR0308870A (pt) 2005-01-04
KR20040094892A (ko) 2004-11-10
EA200401290A1 (ru) 2005-02-24
EA007300B1 (ru) 2006-08-25
WO2003084929A1 (en) 2003-10-16
CN1642914A (zh) 2005-07-20
UA76849C2 (uk) 2006-09-15
MXPA04009640A (es) 2005-01-11
AU2003218147A1 (en) 2003-10-20
ES2248737T3 (es) 2006-03-16
DE60301569D1 (de) 2005-10-13
ZA200407418B (en) 2005-09-15
CN1288135C (zh) 2006-12-06
US20050096328A1 (en) 2005-05-05
ECSP045329A (es) 2004-11-26
HK1070363A1 (en) 2005-06-17
EP1492767A1 (en) 2005-01-05
IL164018A0 (en) 2005-12-18
US7166606B2 (en) 2007-01-23

Similar Documents

Publication Publication Date Title
IS7718A (is) Pýrrólídíndíónútskipt píperídín-þalasón sem PDE4 tálmar
DE602005012634D1 (en) Arylsulfonylnaphthalinderivate als 5ht2a-antagonisten
MX2007005408A (es) Compuestos de aminoquinazolinas.
UA88163C2 (ru) Cgrp-антагонисты, способ их получения, а также их применение как лекарственных средств
IS6902A (is) N-setin heterósýklísk NMDA/NR2B mótlyf sem ekki eru arýl
MX2007000505A (es) Derivados de oxindol sustituidos y medicamentos que contienen los mismos.
RS20050046A (en) 3-z-/1-(4-(n-((4-methyl-piperazin-1-yl)- methylcarbonyl)-n- methyl-amino)- anilino)-1-phenyl-methylene/-6- methoxycarbonyl -2-indolinone- monoethanesulphonate and the use thereof as a pharmaceutical composition
DE60127863D1 (de) Phenylderivate
WO2006047528A3 (en) Pyrazolobenzamides and derivatives as factor xa inhibitors
IL163777A0 (en) Kinase inhibitors
WO2004031145A3 (en) Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors
HK1070363A1 (en) Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serineprotease factor xa
GB0030303D0 (en) Compounds
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
GB0030306D0 (en) Compounds
MX2008001778A (es) Combinacion de un agente hipnotico y un compuesto de bis arilo y heteroarilo sustituido y aplicacion terapeutica de la misma.
MXPA03010205A (es) Derivados de acido oxalico.
DE602004018811D1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
MY137876A (en) Pharmaceutical compound
ATE390419T1 (de) 2-(piperidin-4-yl)-4,5-dihydro-2h-pyridazin-3-o - derivate als pde4-inhibitoren
WO2003076429A3 (en) Azepane derivatives and their use as atk1 inhibitors
AU2002322396A1 (en) 1-glycinyl-4 (methylpiperidin-4-yl) piperazines and -piperridines as factor xa antagonists
TW200603806A (en) Pharmaceutical compound
SI1492767T1 (sl) Dolocene 1-(d-ciklopropilglicinil)-4-(piperidin-4-il)piperazinske spojine kot inhibitorji faktorja xa serinske proteaze
TW200519071A (en) 3-aryl-2-cyano-3-hydroxy-acrylic acid derivatives

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20080304

Year of fee payment: 6

PBON Lapse due to non-payment of renewal fee

Effective date: 20090325